Free EDC Software for Non-Profit COVID-19 Related Studies
Italy-based EDC provider, Nubilaria srl, is offering its ACTide EDC free-of-charge for non-profit COVID-19 related studies due to be performed in Europe. ACTide EDC software is a validated, FDA 21 Part 11 compliant platform featuring native drag and drop eCRFs Designer and modules including RTSM, ePRO, medical coding (MedDRA and WHODurgs) and Safety Dataset.
Nubilaria pledges its maximum commitment possible toward a fast study deployment for all received requests.
The offer applies only to public bodies and any other entity involved in non-profit research.
For further information and to request a demo of the offered service, please visit: https://www.actide.com/nubilaria-offers-the-actide-edc-web-platform-for-free/
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
